Tumour-resident oncolytic bacteria trigger potent anticancer effects through selective intratumoural thrombosis and necrosis
{{output}}
Intratumoural bacteria represent a promising drug-free strategy in cancer therapy. Here we demonstrate that a tumour-resident bacterial consortium-Proteus mirabilis (A-gyo) and Rhodopseudomonas palustris (UN-gyo)-in a precise 3:97 ratio (A-gyo:UN-gyo), exhibit... ...
